Immunophenotyping by Flow Cytometry for Hairy Cell Leukemia Monitoring in UAE | 1800 AED | DNA Labs UAE

Executive Summary & Core Metrics

Executive Summary: Our Hairy Cell Leukemia Monitoring Panel delivers ISO-certified accuracy (>99.9% diagnostic sensitivity) with same-day reporting for blood samples. It is fully compliant with UAE data protection laws and DHA clinical standards.

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM). Hospital extraction for bone marrow aspirates.
Clinical Guidance: Telephonic Post-Test Interpretation by a DHA-licensed specialist.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

This test uses multiparameter flow cytometry to monitor minimal residual disease (MRD) in hairy cell leukemia (HCL) by detecting signature markers (CD103, CD11c, CD25, CD19, CD20). It is the gold standard for assessing treatment response and early relapse in patients under UAE hematology care.

Feature	Our Test (DNA Labs UAE)	Closest Alternative (Standard Panel)
Precision	≥99.9% Diagnostic Sensitivity for HCL markers (CD103+, CD11c+, CD25+)	May miss low-level expression; lower sensitivity
Methodology	8‑Color Multiparameter Flow Cytometry (FACS) with advanced gating	Basic 4‑color immunophenotyping
Turnaround Time	Same‑day report (blood sample by 9 AM) / 24-48 hours (bone marrow)	24–48 hours
Regulatory Compliance	DHA‑aligned, ISO 9001:2015 Certified, PDPL Compliant	May not meet UAE telehealth standards

Physician Insight & Safety Protocols

“As a diagnostic specialist, I understand that precise immunophenotyping is critical for monitoring minimal residual disease in hairy cell leukemia. This panel provides quantifiable data on CD103, CD11c, and CD25 expression, essential for assessing therapeutic response. However, results must always be integrated with the full clinical picture. Our team is committed to providing accurate, actionable results to guide your care.”

— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011

Advisory & Medication Safety

⚠️ Medication Warning: Do not discontinue any prescribed chemotherapy, immunotherapy, or targeted therapy without explicit consultation with your treating oncologist or hematologist.

Safety Exclusion Criteria & Emergency Red Flags

Exclusion: Severely hemolyzed sample; bone marrow clot inadequate; transport outside 18–22°C; missing mandatory clinical history.
Red Flags (seek ER immediately): Sudden high fever (>38.5°C), uncontrolled bleeding/bruising, signs of tumor lysis (muscle cramps, arrhythmia, dark urine).

Pre-Collection Requirements

Clinical history is mandatory. Collect 3 mL whole blood in 1 Lavender Top (EDTA) tube AND 1 Green Top (Sodium Heparin) tube, OR 2 mL bone marrow in 1 Green Top (Sodium Heparin) tube. Ship immediately at 18‑22°C. DO NOT REFRIGERATE OR FREEZE. Blood samples must reach the lab by 9 AM for same‑day report. Bone marrow extraction is a Hospital-Only Procedure conducted strictly within an accredited hospital facility.

Patient FAQ & Clinical Guidance

1. What is the purpose of the Hairy Cell Leukemia Monitoring Panel?

This panel quantifies the abnormal B‑cell population and monitors treatment response. It is essential after chemotherapy or targeted therapy to confirm remission depth and detect early molecular relapse. Your hematologist will interpret the percentage of hairy cells and antigen expression intensity to guide further management.

2. How should I prepare for the blood or bone marrow sample collection?

No fasting is required, but it is crucial to inform our phlebotomist of all current medications, chemotherapy cycles, and any recent transfusions. A detailed clinical history ensures accurate interpretation and prevents pre‑analytical errors. Our VIP home collection team will handle all logistics while maintaining the cold chain integrity.

3. Are there any risks or limitations after the test?

The blood draw or bone marrow aspiration is safe when performed by our DHA‑licensed professionals. After collection, keep the puncture site dry for 24 hours. Rarely, mild discomfort or bruising may occur. Contact our emergency line if you experience heavy bleeding, severe pain, or signs of infection.

UAE Regulatory & Data Privacy Adherence

DNA Labs UAE strictly adheres to the highest standards of clinical data security and patient confidentiality as mandated by:

Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL): Governing the processing and transfer of personal health data.
Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields: Regulating telehealth and digital health information systems.
Federal Decree-Law No. 4 of 2016 on Medical Liability: Ensuring patient safety and clinical governance standards are met during all procedures.

Our DHA Facility License (No. 1143) guarantees full compliance with Dubai Healthcare City Authority (DHCA) regulations for diagnostic testing.

Clinical & Logistical Metadata

Test Name	Immunophenotyping by Flow Cytometry for Hairy Cell Leukemia Monitoring
Price (AED)	1,800 AED
Turnaround Time	Same-day (blood sample by 9 AM) / 24-48 hours (bone marrow aspirate)
Sample Type / Matrix	Whole Blood (EDTA + Sodium Heparin) or Bone Marrow Aspirate
Methodology Used	8‑Color Multiparameter Flow Cytometry (FACS) with Advanced Gating
ICD-10-CM Code	C91.40, C91.41
LOINC Code	100327-6
DHA Facility License & Laboratory Address	DHA License No: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE